Levothyroxine (Elderly)
Brand names: Eltroxin, Euthyrox
This page covers levothyroxine in older patients, the synthetic thyroid hormone (T4) used to treat hypothyroidism; in this group cautious initiation protects against cardiac effects.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is converted to active triiodothyronine (T3) and restores physiological thyroid hormone levels, normalising metabolic rate and tissue function.
Prescribing in practice
- In older patients, and especially those with ischaemic heart disease, start at a low dose and titrate slowly, as rapid correction can precipitate angina, arrhythmia or myocardial ischaemia.
- Take on an empty stomach and apart from interacting agents such as calcium and iron salts, which impair absorption; consistent timing relative to food and other drugs is important.
- Over-replacement risks atrial fibrillation and accelerated bone loss, both of particular concern in older people.
Monitoring
Monitor thyroid function (TSH, with free T4) some weeks after initiation or dose changes and periodically thereafter, allowing time to reach steady state.
Counselling the patient
- Take at the same time each day, usually before food, and separately from calcium or iron supplements.
- Report palpitations, chest pain, tremor or unexpected weight change.
- Do not change the dose yourself; adjustments are guided by blood tests.
Evidence & guidelines
UK thyroid guidance recommends low starting doses and gradual titration of levothyroxine in older patients and those with cardiac disease to avoid precipitating ischaemic events.
Reference: BTA/NICE guidelines; RCP guidance 2019; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- Thyroid Function Interpreter · Thyroid
- Burch-Wartofsky Point Scale for Thyrotoxicosis · Thyroid
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Burch-Wartofsky Score (Thyroid Storm) · Thyroid Crisis
- Thyroid Function Test Interpretation · Thyroid Disease
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5